Comparing Zinc-Amino Acid and Zinc Gluconate for Metabolic Effects
This study is looking at how two different forms of zinc supplements, zinc-amino acid (ZnAA) and zinc gluconate, affect your body's metabolism. Specifically, it's interested in how these supplements impact the 'Response of Fatty Acid Desaturation to Zinc Intake,' which is a process related to how your body uses fats. Researchers want to see if one form of zinc is better than the other at influencing this process. You might be able to join if you are a healthy man between 18 and 50 years old, with a body mass index (BMI) between 18 and 30. The study will measure changes in FADS1 activity, an indicator of this metabolic process, over several weeks. The current status of the study is unclear, and it plans to enroll 30 participants.
- Study design
- This interventional study plans to enroll 30 healthy men. It compares two different zinc supplements to see their effects.
- What's involved
- You would take a zinc supplement daily for 13 days, followed by a two-week break, and then take another zinc supplement for 13 days. You would also have four blood draws over approximately six weeks, each after an 8-hour fast.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your FADS1 activity will be measured at four time points over approximately six weeks, with the last measurement at day 43.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Comparison of the Metabolic Effects of Zinc-Amino Acid (ZnAA) Versus Zinc Gluconate
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- FADS1 activity indexDay 1 (baseline 1), day 15 (endpoint 1), day 29 (baseline 2), day 43 (endpoint 2)
The molar ratio (unitless) of arachidonic acid to dihomo-gamma-linolenic acid, i.e., fatty acid desaturase 1 (FADS1) product to precursor.